99% Savings - Buy Just @1 Rs X
Prorab 10 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Acidity. Other than this, Prorab 10 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Prorab 10 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Prorab 10 Mg Tablet include Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Prorab 10 Mg Tablet as well, which are listed below. Normally, these side effects of Prorab 10 Mg Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Prorab 10 Mg Tablet's effect is Safe during pregnancy and Moderate for lactating mothers. Warnings related to Prorab 10 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Prorab 10 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diarrhea (Loose Motions) are examples of such conditions. The section on Prorab 10 Mg Tablet contraindications lists all such conditions.
Drug interactions for Prorab 10 Mg Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Prorab 10 Mg Tablet is not safe while driving, and is not addiction.
Prorab 10 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Prorab 10 Mg Tablet safe for pregnant women?
Prorab is safe for pregnant women.
Is the use of Prorab 10 Mg Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Prorab. Immediately discontinue Prorab if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Prorab 10 Mg Tablet on the Kidneys?
Prorab does not damage the kidneys.
What is the effect of Prorab 10 Mg Tablet on the Liver?
Prorab may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Prorab 10 Mg Tablet on the Heart?
There are no any side effects of Prorab for the heart.
If you are suffering from any of the following diseases, you should not take Prorab 10 Mg Tablet unless your doctor advises you to do so -
Is this Prorab 10 Mg Tablet habit forming or addictive?
Prorab 10 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Prorab 10 Mg Tablet can make you feel drowsy.
Is it safe?
Yes, the use of Prorab 10 Mg Tablet is considered safe.
Is it able to treat mental disorders?
No, the use of Prorab 10 Mg Tablet in mental disorders is not effective.
Interaction between Food and Prorab 10 Mg Tablet
You can take Prorab 10 Mg Tablet with food.
Interaction between Alcohol and Prorab 10 Mg Tablet
Consumption of alcohol and Prorab 10 Mg Tablet together may have severe effects on your health.
Prorab should be taken for as long as it is prescribed by your doctor. Do not stop taking it or take an extra dose on your own. Always follow the instructions of your doctor completely.
Yes, Prorab is given in combination with itopride. The combination is used for the management of gastro-esophageal reflux disorder (GERD).
Prorab is available in tablet, capsule and injection form. It should be taken exactly as prescribed by your doctor. It can be taken with or without food because food does not affect the absorption of the drug. It should be taken the whole and swallowed with water. It should not be chewed, crushed or split. It should be taken at exactly the same time every day so that there is less chance of missing the dose.
Yes, Prorab use is associated with the development of diarrhea. This might be related to an infection caused by Clostridium difficile. If you experience severe diarrhea after consuming this medicine, inform the doctor right away without further delay. In addition, one must take a lot of electrolytes and fluids for preventing dehydration. Taking an anti-diarrheal medication may also help.
Prorab is a brand name for rabeprazole. It belongs to a class of medications known as proton pump inhibitors. It is available in the form of a tablet, capsule, and injection. Prorab is used to alleviate the symptoms of gastroesophageal reflux disorder (GERD). GERD is a condition in which acid back-flows from the stomach to the esophagus (the tube which connects the stomach with throat) causing heartburn and injury to the esophagus. Prorab is used to prevent this damage. Prorab is also used to treat conditions like Zollinger Ellison syndrome (excessive acid is produced by the stomach). It is used for the treatment of ulcers (sores in the lining of stomach and intestine) and also used in combination with other antibiotics (such as amoxicillin and clarithromycin) to manage H.pylori infection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078